Kyle Moran, Chief Financial Officer at Wave Life Sciences Ltd. (WVE), sold 1,722 shares at $10.57 ($18K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Scheduled sale ($18k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| WVE | SELL | 2024-09-27 | $154K | — | Filing → |
| WVE | SELL | 2024-04-05 | $193K | — | Filing → |
| WVE | SELL | 2023-08-23 | $352K | — | Filing → |